To test this hypothesis, we attempted to suppress pro-inflammatory gene activity in RAG−/− mice by blocking TNF signaling with a neutralizing antibody, which has been shown to decrease IL-1β production in models of sepsis [31] and arthritis [32]. Here, IL1B is linked to arthritic joint disease.